Israel: closes US$60m Series C

Tel Aviv-based has closed its US$60m Series C funding round and received 510(k) clearance from the US Food and Drug Administration (FDA) for its smartphone-based ACR test used to diagnose chronic kidney disease. The round was led by Corner Ventures with participation by Joy Capital and all previous investors: Ansonia Holdings, Aleph, and Samsung…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »